Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
Authors
Dani Ran Castillo
City of Hope National Cancer Center, Duarte, CA
Dani Ran Castillo , Won Jin Jeon , Esther G Chong , Jae Y. Kim , S.Peter Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 257)
DOI
10.1200/JCO.2024.42.3_suppl.257
Abstract #
257
Poster Bd #
B15
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
The effect of adjuvant chemotherapy in patients without local nodal metastases following neoadjuvant chemoradiotherapy and esophagectomy for locally advanced esophageal cancer.
First Author: Christopher Duane Nevala-Plagemann
Poster
2017 Gastrointestinal Cancers Symposium
Toxicity and survival in older versus younger esophageal cancer (EC) patients (pts) treated with neoadjuvant chemoradiotherapy (nCRT).
First Author: Rishi Jain
Poster
2017 Gastrointestinal Cancers Symposium
Effect of extending the original eligibility criteria for the “CROSS” neoadjuvant chemoradiotherapy on toxicity and survival in esophageal cancer.
First Author: Jan-Binne Hulshoff
Poster
2016 Gastrointestinal Cancers Symposium
Accuracy of clinical staging with EUS for early stage esophageal cancer: Are we denying patients beneficial neoadjuvant chemo-radiation?
First Author: Carrie Luu